IRCT201406169014N36.

Study name	The effect of Cerebrolysin versus placebo on improvement of patients with acute ischemic stroke: a double blinded randomized clinical trial
Methods	Interventional, randomised, parallel‐group, double‐blind (clinical trial)
Participants	122 participants aged 45 to 85 years with ischaemic stroke, referred to the hospital within less than 24 hours after stroke
Interventions	Intervention: Cerebrolysin 10 mL in 100 mL normal saline daily for 7 days added to routine therapy Control: placebo ‐ 100 mL normal saline alone daily for 7 days added to routine therapy
Outcomes	Primary: measuring motor function before intervention and 3 and 7 days after intervention using Canadian Stroke Scale Secondary: measuring motor function 1 month after intervention using modified Rankin Scale and Bartel Index
Starting date	23 July 2013; retrospective registration; no results posted
Contact information	Sajedeh Nazari, Farshchian Hospital, Mirzadeh Eshghi Ave, Hamadan, Iran (Islamic Republic of); +98 81 3264 0021; sajed_nazari@yahoo.com
Notes	Funding: Dr Saeid Bashirian, Vice‐chancellor for Research the Technology, Hamadan University of Medical Sciences